These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 29547962

  • 21. 'It's not my greengrocer, it's someone from the medical profession': A qualitative study regarding acceptability of deceptive and open-label placebo prescribing in France.
    Druart L, Vauthrin O, Pinsault N, Locher C, Blease C.
    Br J Health Psychol; 2023 May; 28(2):273-290. PubMed ID: 36086862
    [Abstract] [Full Text] [Related]

  • 22. Are open-Label Placebos Ethical? Informed Consent and Ethical Equivocations.
    Blease C, Colloca L, Kaptchuk TJ.
    Bioethics; 2016 Jul; 30(6):407-14. PubMed ID: 26840547
    [Abstract] [Full Text] [Related]

  • 23. Are Blue Pills Better Than Green? How Treatment Features Modulate Placebo Effects.
    Meissner K, Linde K.
    Int Rev Neurobiol; 2018 Jul; 139():357-378. PubMed ID: 30146054
    [Abstract] [Full Text] [Related]

  • 24. Placebos Without Deception: Outcomes, Mechanisms, and Ethics.
    Colloca L, Howick J.
    Int Rev Neurobiol; 2018 Jul; 138():219-240. PubMed ID: 29681327
    [Abstract] [Full Text] [Related]

  • 25. Open-Label Placebo Interventions With Drinking Water and Their Influence on Perceived Physical and Mental Well-Being.
    Rathschlag M, Klatt S.
    Front Psychol; 2021 Jul; 12():658275. PubMed ID: 34938222
    [Abstract] [Full Text] [Related]

  • 26. Open-Label Placebos Improve Symptoms in Allergic Rhinitis: A Randomized Controlled Trial.
    Schaefer M, Harke R, Denke C.
    Psychother Psychosom; 2016 Jul; 85(6):373-374. PubMed ID: 27744433
    [No Abstract] [Full Text] [Related]

  • 27. The effect of placebo administration on the first-night effect in healthy young volunteers.
    Suetsugi M, Mizuki Y, Yamamoto K, Uchida S, Watanabe Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May 09; 31(4):839-47. PubMed ID: 17328999
    [Abstract] [Full Text] [Related]

  • 28. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.
    Plazzi G, Ruoff C, Lecendreux M, Dauvilliers Y, Rosen CL, Black J, Parvataneni R, Guinta D, Wang YG, Mignot E.
    Lancet Child Adolesc Health; 2018 Jul 09; 2(7):483-494. PubMed ID: 30169321
    [Abstract] [Full Text] [Related]

  • 29. Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1.
    Land SR, Walcott FL, Liu Q, Wickerham DL, Costantino JP, Ganz PA.
    J Natl Cancer Inst; 2016 Apr 09; 108(4):. PubMed ID: 26615179
    [Abstract] [Full Text] [Related]

  • 30. The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial.
    Huttner A, Dayer JA, Yerly S, Combescure C, Auderset F, Desmeules J, Eickmann M, Finckh A, Goncalves AR, Hooper JW, Kaya G, Krähling V, Kwilas S, Lemaître B, Matthey A, Silvera P, Becker S, Fast PE, Moorthy V, Kieny MP, Kaiser L, Siegrist CA, VSV-Ebola Consortium.
    Lancet Infect Dis; 2015 Oct 09; 15(10):1156-1166. PubMed ID: 26248510
    [Abstract] [Full Text] [Related]

  • 31. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 09; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 32. Deceptive but not open label placebos attenuate motion-induced nausea.
    Barnes K, Yu A, Josupeit J, Colagiuri B.
    J Psychosom Res; 2019 Oct 09; 125():109808. PubMed ID: 31426018
    [Abstract] [Full Text] [Related]

  • 33. Open-label placebo reduces fatigue in cancer survivors: a randomized trial.
    Zhou ES, Hall KT, Michaud AL, Blackmon JE, Partridge AH, Recklitis CJ.
    Support Care Cancer; 2019 Jun 09; 27(6):2179-2187. PubMed ID: 30298411
    [Abstract] [Full Text] [Related]

  • 34. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment.
    Hróbjartsson A, Gøtzsche PC.
    N Engl J Med; 2001 May 24; 344(21):1594-602. PubMed ID: 11372012
    [Abstract] [Full Text] [Related]

  • 35. [Appearances are not deceptive: clinical evidence and new research approaches to open-label placebo].
    Nestoriuc Y, Kleine-Borgmann J.
    Nervenarzt; 2020 Aug 24; 91(8):708-713. PubMed ID: 32691079
    [Abstract] [Full Text] [Related]

  • 36. Evidencing general acceptability of open-label placebo use for tackling overtreatment in primary care: a mixed methods study.
    Krockow EM, Emerson T, Youssef E, Scott S, Tromans S.
    BMC Med; 2023 Sep 19; 21(1):362. PubMed ID: 37726759
    [Abstract] [Full Text] [Related]

  • 37. Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis.
    Meissner K, Fässler M, Rücker G, Kleijnen J, Hróbjartsson A, Schneider A, Antes G, Linde K.
    JAMA Intern Med; 2013 Nov 25; 173(21):1941-51. PubMed ID: 24126676
    [Abstract] [Full Text] [Related]

  • 38. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
    Pauer L, Winkelmann A, Arsenault P, Jespersen A, Whelan L, Atkinson G, Leon T, Zeiher B, A0081100 Investigators.
    J Rheumatol; 2011 Dec 25; 38(12):2643-52. PubMed ID: 21965636
    [Abstract] [Full Text] [Related]

  • 39. Quetiapine : A Review of its Use in Schizophrenia.
    Gunasekara NS, Spencer CM.
    CNS Drugs; 1998 Apr 25; 9(4):325-40. PubMed ID: 27521016
    [Abstract] [Full Text] [Related]

  • 40. Placebos in the era of open-label trials: An update for clinicians.
    Sagy I, Abres J, Winnick A, Jotkowitz A.
    Eur J Clin Invest; 2019 Jan 25; 49(1):e13038. PubMed ID: 30316203
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.